Korean J Med.  2017 Jun;92(3):245-250. 10.3904/kjm.2017.92.3.245.

Guidelines for the Postoperative Treatment of Thyroid Cancer: Levothyroxine and Calcium/Vitamin D Supplements

Affiliations
  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. ldj6026@catholic.ac.kr

Abstract

Thyroid hormone replacement is required after surgery for thyroid cancer to manage postoperative hypothyroidism and for thyroid-stimulating hormone (TSH) suppression therapy. However, considering the increased risks of cardiovascular disease and osteoporosis as a result of excessive thyroid hormone administration, it is necessary to maintain the correct dose. This requires prescription strategies tailored to the patient's individual TSH goals by assessing the risk of recurrence, response to treatment, and risk factors for thyroid hormone therapy. In addition, if hypocalcemia is observed or symptoms of hypocalcemia are detected postoperatively, calcium and vitamin D should be administered to improve the symptoms and maintain serum calcium levels within normal ranges.

Keyword

Thyroid cancer; Hypoparathyroidism; Calcium; Vitamin D

MeSH Terms

Calcium
Cardiovascular Diseases
Hypocalcemia
Hypoparathyroidism
Hypothyroidism
Osteoporosis
Prescriptions
Recurrence
Reference Values
Risk Factors
Thyroid Gland*
Thyroid Neoplasms*
Thyrotropin
Thyroxine*
Vitamin D
Calcium
Thyrotropin
Thyroxine
Vitamin D
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr